Status update: Ebola outbreak in Uganda continues. While risk of international spread remains limited, Canada has implemented a travel health notice including screening at t
Newsroom
Medical Staff Recruitment and Retention has released the Medical Staff Recruitment and Retention Newsletter for October 2022.
November 2022 formulary update - effective November 9, 2022
Included in the update:
The issue: Due to the shortage of Canadian-labelled lorazepam 4 mg/mL X 1 mL vials from Sandoz, Health Canada has authorized the importation of a US-labelled product from Hikma.
The issue: Haloperidol 0.5 mg, 1 mg, 2 mg, 5 mg and 10 mg oral tablets are on backorder from the only manufacturer in Canada (Teva). NH has a good supply of haloperidol 1 mg tablets, but stock levels of all other strengths may not meet future demands.
The issue: Calcitonin 200 units/mL X 2 mL injectable is on backorder from the only manufacturer in Canada. Some NH supply will also be expiring on October 31st, 2022, resulting in stock levels of approximately 3 to 4 weeks remaining.
During the 2022-2023 respiratory season, Northern Health microbiology labs will be performing multiplexed testing and reporting for influenza A, influenza B, RSV and SARS-CoV-2 when requested for eligible individuals.